Find clinical trials for oncology. Search for oncology clinical trials in different cities and states across the United States.
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT03916627
Conditions
Non-small Cell Lung Cancer
Hepatocellular Carcinoma
Head and Neck Squamous Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
cemiplimab
Platinum Doublet
fianlimab
Sponsor:
Northwestern University
Location:
Code:
NCT06081127
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MOve-ABC
Enhanced Usual Care
Sponsor:
M.D. Anderson Cancer Center
Location:
Code:
NCT01515527
Conditions
Leukemia
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Interventions
Cladribine
Cytarabine
Decitabine
Sponsor:
Alliance for Clinical Trials in Oncology
Location:
Code:
NCT06632327
Conditions
Resectable Lung Non-Small Cell Carcinoma
Stage II Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Stage IIIB Lung Cancer AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Surgical Procedure
Cisplatin
Carboplatin
Pemetrexed
Gemcitabine
Sponsor:
McGill University
Location:
Code:
NCT02288676
Conditions
Ovarian Neoplasms
Endometrial Neoplasms
Endometrial Cancer
Ovarian Cancer
Screening
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Sponsor:
Brigham and Women's Hospital
Location:
Code:
NCT06538376
Conditions
Pulmonary Edema
Pneumonia
Atelectasis
Pleural Effusion
Acute Rejection of Lung Transplant (Disorder)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Portable Dynamic Digital Radiography (DDR)
Sponsor:
Christian Hinrichs
Location:
Code:
NCT05483491
Conditions
Gastric Cancer
Breast Cancer
Cervical Cancer
Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
KK-LC-1 TCR-T cells
Aldesleukin
Sponsor:
University Medical Center Nijmegen
Location:
Code:
NCT04294927
Conditions
BRCA1 Gene Mutation
BRCA2 Gene Mutation
RAD51C Gene Mutation
RAD51D Gene Mutation
BRIP1 Gene Mutation
Eligibility Criteria
Sex: Female
Age: 25 - 50
Healthy Volunteers: Not accepted
Interventions
Risk-reducing salpingectomy with delayed oophorectomy
Risk-reducing salpingo-oophorectomy
Sponsor:
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Location:
Code:
NCT04471727
Conditions
Small-Cell Lung Cancer
Neuroendocrine Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
MK-6070
Atezolizumab
Ifinatamab Deruxtecan (I-DXd)
Clinical trials for cancer are research studies that aim to evaluate new ways to prevent, detect, or treat cancer. These trials test the safety and effectiveness of new treatments, procedures, or drugs in comparison to current standards. They may also show which medical approaches work best for certain types of cancer or groups of people.
Cancer clinical trials are crucial for developing new methods to fight cancer, improving patient outcomes, and may offer participants access to cutting-edge therapies before they are widely available.
Oncology clinical trials are designed to address different aspects of cancer care, including how to treat cancer, prevent it, find it early, or improve the quality of life for people with cancer. The main types are:
Treatment trials test new treatments or new combinations of treatments, such as new drugs, new surgical techniques, or new radiation therapies. The goal is to find more effective ways to treat cancer with fewer side effects.
Prevention trials look for better ways to prevent cancer in people who have never had cancer or to prevent cancer from returning. These trials may include studying medicines, vaccines, vitamins, minerals, or lifestyle changes.
Screening trials test the best way to detect cancer, especially in its early stages. These trials study new examinations or tests that might be more effective, safer, or less invasive than the current standard screening methods.
Quality of life trials (or supportive care trials) explore ways to improve comfort and the quality of life for individuals with terminal types of cancer and cancer survivors. They may study issues such as managing side effects of treatment, physical, psychological, and social side effects of cancer and its treatment.
Eligibility for oncology trials varies widely depending on the study's objectives. Factors can include the type and stage of cancer, previous treatment history, age, gender, overall health, and other medical conditions. Researchers conducting the trial set specific criteria for each trial to ensure accurate and reliable results and to keep participants safe.
Participating in a cancer clinical trial often involves detailed screenings, regular health check-ups, and a structured treatment plan. Participants may receive the new treatment being tested, a standard treatment for their cancer, or a placebo, depending on the trial's design. Throughout the trial, researchers will monitor the health of participants and the effectiveness and side effects of the treatment.
Participating in cancer clinical trials offers potential benefits, including access to new treatments before they are widely available and contributing to medical research that may benefit others in the future. They also receive close monitoring from a dedicated healthcare team.
However, there are also risks, such as the new treatments under study are not always better than the standard care, and there may be unexpected side effects. Participation may also require more of their time and attention, including trips to the study site, more treatments, hospital stays, or complex dosage requirements.
Unsure about participating in clinical trials? Dive into our comprehensive guide to learn about the process, benefits, and potential impact of your involvement. Get the facts you need to make an informed decision today!
Enrolling in a cancer clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: